abelheira schreef op 22 november 2019 09:10:
[...]
In September 2018, Gilead’s faith in Galapagos paid off with positive results from FINCH 2, the first RA trial in phase 3 to end positively for filgotinib. More positive data followed in FINCH 3 in March 2019.
FINCH 1 as still ongoing at the time. NDA is planned for late-2019, which will help GILD, but will surely boost GLPG even more.
Is Finch 1 nog niet afgelopen???